Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

Lili Du, Christina Yau, Lamorna Brown Swigart, Rebekah Gould, Gregor Krings, Gillian L. Hirst, Isabelle Bedrosian, Rachel M. Layman, Jodi M. Carter, Martin Klein, Sara J. Venters, Sonal Shad, Marieke van der Noordaa, A. Jo Chien, Tufia C. Haddad, Claudine Isaacs, Lajos Pusztai, Kathy S. Albain, Rita Nanda, Debu Tripathy, M.C. Liu, Judy C. Boughey, Richard B. Schwab, Nola M. Hylton, Angela DeMichele, Jane Perlmutter, Douglas Yee, Donald A. Berry, Laura van’t Veer, Vicente Valero, Laura J. Esserman, W. Fraser Symmans